Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
11:20
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

52nd ERA-EDTA Congress

 

28-31 May 2015 London
FAQs
   
Discussion forum - 52nd ERA-EDTA Congress
    Topic - K2) Diabetes - Clinical studies.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
RENAL BIOPSY IN DIABETIC PATIENTS: A META-ANALYSIS AND META-REGRESSION OF 48 STUDIES  Marco Fiorentino 2      7/16/2021 2:25:00 PM  
ACHIEVING OPTIMAL DIABETES CARE; IS IT TIME TO RETHINK THE MANAGEMENT OF DIABETIC HAEMODIALYSIS PATIENTS?  Emily McQuarrie 1      5/18/2015 8:54:00 PM  
IMPACT OF AUTOLOGOUS BONE MARROW-DERIVED STEM CELLS TO MARKERS OF RENAL DETERIORATION IN TYPE 1 DIABETES MELLITUS WITH NEPHROPATHY  Abduzhappar GAIPOV 1      5/18/2015 8:27:00 PM  
EFFECT OF HEMODIALYSIS MODALITY ON ALL CAUSE MORTALITY OF DIABETIC PATIENTS- 36 MONTHS FOLLOW UP  Petar Djuric 1      5/18/2015 8:13:00 PM  
INCREASED SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A ARE REVERSELY CORRELATED WITH TIMP-1 IN ATHEROSCLEROSIS IN EARLY STAGES OF TYPE 2 DIABETIC NEPHROPATHY  GRIGORIOS DIMAS 1      5/18/2015 5:25:00 PM  
STUDY INTO THE EFFECT OF AQUAPORIN-2 ON THE EFFICACY AND PREDICTED EFFECT OF TOLVAPTAN IN PATIENTS OF NEPHROTIC SYNDROME  Eiichi Sato 1      5/17/2015 6:27:00 PM  
RISK FACTORS FOR NON-DIABETIC NEPHROPATHY IN DIABETIC PATIENTS  Sheila Bermejo 1      5/15/2015 4:49:00 PM  
CD362 MESENCHYMAL STEM CELL TREATMENT OF KIDNEY DISEASE IN TYPE 2 DIABETIC LEPR DB/DB MICE.  Satish Kumar Devarapu 1      5/15/2015 10:54:00 AM  
RELATIONSHIP BETWEEN SYSTOLIC BLOOD PRESSURE AND RISK OF CARDIOVASCULAR EVENTS AND ALL CAUSE OF MORTALITY IN PATIENTS WITH TYPE 2 DIABETES AND RENAL IMPAIREMNT IN THE PRESENCE OR ABSENCE OF ALBUMINURIA- THE SWEDISH NATIONAL DAIBETES REGISTER (NDR).  Hanri Afghahi 1      5/15/2015 9:32:00 AM  
ORAL TREATMENT WITH PBI-4547, A NOVEL FIRST-IN-CLASS ANTI-DIABETIC AND ANTI-FIBROTIC COMPOUND, IMPROVES GLOMERULAR FUNCTION AND PREVENTS PODOCYTE INJURY IN THE DIABETIC DB/DB MOUSE MODEL  Brigitte Grouix 1      5/14/2015 11:51:00 PM  
BOTH LOW AND HIGH SYSTOLIC BLOOD PRESSURE INCREASES THE RISK OF CARDIOVASCULAR EVENTS AND ALL-CAUSE OF MORTALITY IN PATIENTS WITH TYPE 2-DIABETES AND RENAL IMPAIRMENT WITHOUT PREVIOUS CARDIOVASCULAR DISEASE OR CONGESTIVE HEART FAILURE  Maria Svensson 1      5/11/2015 11:37:00 AM  
THE EFFECT OF DIFFERENT ANTIHYPERTENSIVE TREATMENT PROTOCOLES ON OXIDANT-ANTIOXIDANT SYSTEMS IN TYPE 2 DIABETIC PATIENTS WITH MICROALBUMINURIA AND STAGE 1 HYPERTENSION  Alparslan Ersoy 1      5/10/2015 10:17:00 PM  
CIRCULATING TNF RECEPTOR LEVELS AND RENAL DISEASE PROGRESSION IN PATIENTS WITH TYPE 2 DIABETIC NEPHROPATHY AND BLOCKADE OF THE RENIN ANGIOTENSIN SYSTEM  Gema María Fernández Juárez 1      5/9/2015 12:48:00 PM  
URINARY PODOCYTES ARE ASSOCIATED WITH PROXIMAL TUBULE DYSFUNCTION IN TYPE 2 DIABETES MELLITUS PATIENTS: A CROSS-SECTIONAL STUDY  Ligia Petrica 1      5/3/2015 10:02:00 PM  
TREATMENT WITH A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST LIRAGLUTIDE DECREASES ALBUMINURIA IN OVERWEIGHT TYPE 2 DIABETIC PATIENTS  Tomislav Bulum 1      5/2/2015 6:46:00 PM  
METFORMIN USE IN DIABETES MELLITUS WITH CHRONIC KIDNEY DISEASE - IS LACTIC ACIDOSIS A REAL CONCERN ?  Ravindra Prabhu Attur 1      4/25/2015 7:03:00 PM  
       




Most viewed poster for this congress
Poster: 625
Visits: 3858
Title: IS 4 CITRATE AN EFFECTIVE TOOL AS A CATHETER LOCKING SOLUTION?
Authors: Joao Fazendeiro Matos ,
Centre: Fresenius Medical Care | NephroCare Portugal

Poster most viewed in this topic
Poster: 47
Visits: 172
Title: ORAL TREATMENT WITH PBI-4547, A NOVEL FIRST-IN-CLASS ANTI-DIABETIC AND ANTI-FIBROTIC COMPOUND, IMPROVES GLOMERULAR FUNCTION AND PREVENTS PODOCYTE INJURY IN THE DIABETIC DB/DB MOUSE MODEL
Authors: Brigitte Grouix , Kathy Hince, Franois Sarra-Bournet, Alexandra Felton, Mikal Tremblay, Marie-Pier Cloutier, Shaun Abbott, Jean-Simon Duceppe, Boulos Zacharie, Pierre Laurin and Lyne Gagnon
Centre: ProMetic BioSciences Inc.


 






PosterSessionOnline
Logo Draft
 
Logo Cert